(Q46427835)

22 December 2017

title

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells (English)

1 reference

22 December 2017

author name string

John Wharton

1

1 reference

22 December 2017

Julian W Strange

2

1 reference

22 December 2017

Gigi M O Møller

3

1 reference

22 December 2017

Ellena J Growcott

4

1 reference

22 December 2017

Xiaohui Ren

5

1 reference

22 December 2017

Angela P Franklyn

6

1 reference

22 December 2017

Stephen C Phillips

7

1 reference

22 December 2017

Martin R Wilkins

8

1 reference

22 December 2017

language of work or name

English

0 references

publication date

7 April 2005

1 reference

22 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

22 December 2017

volume

172

1 reference

22 December 2017

page(s)

105-113

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Cyclic GMP phosphodiesterases and regulation of smooth muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Sildenafil citrate vs intracavernous alprostadil for patients with arteriogenic erectile dysfunction: a randomised placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1587OC

10.1164/RCCM.200411-1587OC

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15817798

1 reference

22 December 2017